Showing results (661-670 of 994) with videos related to

Sort By:
Pageof 100
Leukemia|February 13, 2014
A novel Bruton's tyrosine kinase inhibitor CC-292 in combination with the proteasome inhibitor carfilzomib impacts the bone microenvironment in a multiple myeloma model with resultant antimyeloma activityH Eda, L Santo, D D Cirstea, et al.
British Journal of Haematology|April 18, 2022
Inhibition of the Sec61 translocon overcomes cytokine-induced glucocorticoid resistance in T-cell acute lymphoblastic leukaemiaLauren K Meyer, Cristina Delgado-Martin, Phillip P Sharp, et al.
Lancet (London, England)|July 26, 2005
Radiotherapy versus single-dose carboplatin in adjuvant treatment of stage I seminoma: a randomised trialR T D Oliver, M D Mason, G M Mead, et al.
Haematologica|September 24, 2013
Higher ratio immune versus constitutive proteasome level as novel indicator of sensitivity of pediatric acute leukemia cells to proteasome inhibitorsDenise Niewerth, Niels E Franke, Gerrit Jansen, et al.
Communications Biology|November 28, 2024
Host DNA depletion on frozen human respiratory samples enables successful metagenomic sequencing for microbiome studiesMinsik Kim, Raymond C Parrish, Michael J Tisza, et al.
Nature Medicine|June 16, 2009
A selective inhibitor of the immunoproteasome subunit LMP7 blocks cytokine production and attenuates progression of experimental arthritisTony Muchamuel, Michael Basler, Monette A Aujay, et al.
Familial Cancer|May 10, 2020
Evaluation of implementation of risk management guidelines for carriers of pathogenic variants in mismatch repair genes: a nationwide audit of familial cancer clinicsB Meiser, R Kaur, J Kirk, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 20, 2007
18fluorodeoxyglucose positron emission tomography in the prediction of relapse in patients with high-risk, clinical stage I nonseminomatous germ cell tumors: preliminary report of MRC Trial TE22--the NCRI Testis Tumour Clinical Study GroupRobert A Huddart, Michael J O'Doherty, Anwar Padhani, et al.
International Journal of Neonatal Screening|December 18, 2019
Next Generation Sequencing in Newborn Screening in the United Kingdom National Health ServiceJulia C van Campen, Elizabeth S A Sollars, Rebecca C Thomas, et al.
Leukemia|September 24, 2011
Impaired bortezomib binding to mutant β5 subunit of the proteasome is the underlying basis for bortezomib resistance in leukemia cellsN E Franke, D Niewerth, Y G Assaraf, et al.
Pageof 100